Literature DB >> 7489494

Inhibition of the hammerhead ribozyme by neomycin.

T K Stage1, K J Hertel, O C Uhlenbeck.   

Abstract

A series of antibiotics was tested for stimulation or inhibition of the hammerhead ribozyme cleavage reaction. Neomycin was found to be a potent inhibitor of the reaction with a Kl of 13.5 microM. Two hammerheads with well-characterized kinetics were used to determine which steps in the reaction mechanism were inhibited by neomycin. The data suggest that neomycin interacts preferentially with the enzyme-substrate complex and that this interaction leads to a reduction in the cleavage rate by stabilizing the ground state of the complex and destabilizing the transition state of the cleavage step. A comparison of neomycin with other aminoglycosides and inhibitors of hammerhead cleavage implies that the ammonium ions of neomycin are important for the antibiotic-hammerhead interaction.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7489494      PMCID: PMC1369065     

Source DB:  PubMed          Journal:  RNA        ISSN: 1355-8382            Impact factor:   4.942


  36 in total

Review 1.  Correction of genetic disease by making sense from nonsense.

Authors:  R J Kaufman
Journal:  J Clin Invest       Date:  1999-08       Impact factor: 14.808

2.  Rapid kinetic characterization of hammerhead ribozymes by real-time monitoring of fluorescence resonance energy transfer (FRET).

Authors:  K K Singh; R Parwaresch; G Krupp
Journal:  RNA       Date:  1999-10       Impact factor: 4.942

Review 3.  Aminoglycosides: perspectives on mechanisms of action and resistance and strategies to counter resistance.

Authors:  L P Kotra; J Haddad; S Mobashery
Journal:  Antimicrob Agents Chemother       Date:  2000-12       Impact factor: 5.191

4.  Inhibition of RNase P RNA cleavage by aminoglycosides.

Authors:  N E Mikkelsen; M Brännvall; A Virtanen; L A Kirsebom
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

5.  Inhibition of protein synthesis by aminoglycoside-arginine conjugates.

Authors:  Marjolaine Carriere; Veerappan Vijayabaskar; Drew Applefield; Isabelle Harvey; Philippe Garneau; Jon Lorsch; Aviva Lapidot; Jerry Pelletier
Journal:  RNA       Date:  2002-10       Impact factor: 4.942

6.  Effect of peptidyltransferase inhibitors on ribonuclease P activity from Dictyostelium discoideum. Effect of antibiotics on RNase P.

Authors:  C Stathopoulos; A Tsagla; A Tekos; D Drainas
Journal:  Mol Biol Rep       Date:  2000-06       Impact factor: 2.316

7.  Using pyrene-labeled HIV-1 TAR to measure RNA-small molecule binding.

Authors:  Kenneth F Blount; Yitzhak Tor
Journal:  Nucleic Acids Res       Date:  2003-10-01       Impact factor: 16.971

8.  A peptide nucleic acid-aminosugar conjugate targeting transactivation response element of HIV-1 RNA genome shows a high bioavailability in human cells and strongly inhibits tat-mediated transactivation of HIV-1 transcription.

Authors:  Indrajit Das; Jérôme Désiré; Dinesh Manvar; Isabelle Baussanne; Virendra N Pandey; Jean-Luc Décout
Journal:  J Med Chem       Date:  2012-06-22       Impact factor: 7.446

9.  Complete thermodynamic characterization of the multiple protonation equilibria of the aminoglycoside antibiotic paromomycin: a calorimetric and natural abundance 15N NMR study.

Authors:  Christopher M Barbieri; Daniel S Pilch
Journal:  Biophys J       Date:  2005-12-02       Impact factor: 4.033

10.  Screening for engineered neomycin riboswitches that control translation initiation.

Authors:  Julia E Weigand; Martin Sanchez; Ewald-Bernd Gunnesch; Sabrina Zeiher; Renee Schroeder; Beatrix Suess
Journal:  RNA       Date:  2007-11-13       Impact factor: 4.942

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.